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Abstract
Background—The objective of this analysis was to evaluate the frequency, distribution of 
potential etiologies, and survival rates of maternal cardiopulmonary arrest during the 
hospitalization for delivery in the United States.
Methods—By using data from the Nationwide Inpatient Sample during the years 1998 through 
2011, the authors obtained weighted estimates of the number of U.S. hospitalizations for delivery 
complicated by maternal cardiac arrest. Clinical and demographic risk factors, potential etiologies, 
and outcomes were identified and compared in women with and without cardiac arrest. The 
authors tested for temporal trends in the occurrence and survival associated with maternal arrest.
Results—Cardiac arrest complicated 1 in 12,000 or 8.5 per 100,000 hospitalizations for delivery 
(99% CI, 7.7 to 9.3 per 100,000). The most common potential etiologies of arrest included 
hemorrhage, heart failure, amniotic fluid embolism, and sepsis. Among patients with cardiac 
arrest, 58.9% of patients (99% CI, 54.8 to 63.0%) survived to hospital discharge.
Conclusions—Approximately 1 in 12,000 hospitalizations for delivery is complicated by 
cardiac arrest, most frequently due to hemorrhage, heart failure, amniotic fluid embolism, or 
sepsis. Survival depends on the underlying etiology of arrest.
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Cardiopulmonary arrest is a rare complication during pregnancy and the postpartum period. 
A number of unique interventions must be considered during resuscitation of the pregnant 
arrest victim, including the use of left uterine displacement, prompt and often challenging 
airway management, and an emergent operative delivery of the fetus. The International 
Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science 
states that “research in the area of maternal resuscitation is lacking, and most of the science 
is extrapolated from nonpregnant women, manikin studies, or case reports.”1 The committee 
members called for “epidemiological studies… to document the incidence of cardiac arrest 
in pregnancy as there is a perception that it is increasing because of increased numbers of 
women with congenital heart conditions who are now having children.”1
The frequency of maternal cardiopulmonary arrest in the United States is unknown, and 
there are limited population- level data to inform guideline development or systems 
preparations for these rare emergencies. The objective of this analysis was to determine the 
frequency, distribution of potential etiologies, and survival rates of maternal 
cardiopulmonary arrest during delivery hospitalizations in the United States to provide 
insights into potentially avoidable maternal morbidity and mortality.
Materials and Methods
Data for the study were derived from the Nationwide Inpatient Sample (NIS), which is the 
largest all-payer discharge database available in the United States. The database is 
maintained as part of the Healthcare Cost and Utilization Project sponsored by the Agency 
for Healthcare Research and Quality.
The NIS is a stratified sample of approximately 20% of all annual U.S. hospital admissions 
and is designed to represent all admissions to non-Federal hospitals. To create a 
representative sample, hospitals are selected for inclusion in the NIS based on five 
characteristics: the number of beds, teaching status, urban/rural location, region (divided 
into Northeast, South, Midwest, and West), and ownership. Each year, approximately 1,000 
hospitals are selected for inclusion with information from all admissions from those 
hospitals incorporated into the database. The NIS contains sample weights for each of these 
hospitals which can be applied to obtain national estimates. Additional information on the 
methodology used to create the NIS can be found on the Healthcare Cost and Utilization 
Project Web site.* For each patient, the NIS includes age, race, primary expected payer, and 
up to 15 diagnostic and 15 procedural codes defined in the International classification of 
Diseases, Ninth Revision, Clinical Modification.†
Inclusion and Exclusion Criteria
We identified all admissions for delivery in the NIS between 1998 and 2011 using a 
validated coding algorithm of diagnosis and procedure codes, as defined by Kuklina et al.2 
Because Diagnosis-Related Group codes changed during the study period, these were not 
*HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Rockville, MD, Agency for Healthcare 
Research and Quality, 1998–2007. Available at: http://www.hcup-us.ahrq.gov/. Accessed September 27, 2013.
†Center for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-
CM), 2011. Available at: http://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed September 27, 2013.
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used for selection. Hospitalizations were included if they had a diagnosis code indicating 
delivery or a procedure code related to delivery (e.g., forceps, breech extraction, vacuum 
extraction, version and extraction, manually assisted deliveries, episiotomy, hysterotomy, or 
cesarean delivery). Hospitalizations were excluded if they had a diagnosis code indicating 
abnormal products of conception (i.e., hydatidiform mole or ectopic pregnancy) or a 
procedure code indicating abortion.
Outcomes
The primary outcome measure was the population-based incidence of maternal cardiac arrest 
during hospitalization for delivery in the United States between 1998 and 2011. Secondary 
outcome measures included: (1) survival to hospital discharge; (2) the association between 
maternal cardiac arrest and demographic and socioeconomic characteristics, and medical 
and obstetric diagnoses and procedures; and (3) the association between maternal cardiac 
arrest and the annual hospital delivery volume. Annual hospital delivery volume was 
calculated for each hospital by summing all deliveries taking place at the hospital and 
dividing by the number of years the hospital was included in the study.
Among those hospitalized for delivery, cardiac arrest was defined based on International 
Classification of Diseases, Ninth Revision, Clinical Modification diagnostic and procedure 
codes including: 99.60 (cardiopulmonary resuscitation, not otherwise specified), 99.63 
(closed-chest cardiac massage), and 37.91 (open-chest cardiac massage) and diagnosis codes 
including 427.5 (cardiac arrest) and 427.41 (ventricular fibrillation). Cases coded as 668.1 
(cardiac complications after anesthesia or sedation in labor and delivery) and 669.4 (other 
complications of obstetrical procedures) were not included in the outcome measure, because 
these codes encompass a spectrum of outcomes and are not specific to cardiac arrest.
We examined the distribution of maternal demographic factors (i.e., age, race), data 
potentially representing socioeconomic status (i.e., primary payer), and coexisting medical 
conditions and obstetric conditions and procedures in patients with and without cardiac 
arrest (i.e., malignancy, pulmonary hypertension, ischemic heart disease, congenital heart 
disease, cardiac valvular disease, pre-existing hypertension, liver disease of pregnancy, 
systemic lupus erythematosus, drug abuse or dependence, asthma, chronic renal disease, 
sickle cell disease, and diabetes mellitus, stillbirth, severe preeclampsia, placenta previa, 
chorioamnionitis, multiple gestation, and cesarean delivery). Sociodemographic variables 
including age, race, and primary expected payer were recorded directly from the NIS 
dataset. Medical and obstetrical conditions and obstetrical procedures were defined with the 
use of previously reported coding algorithms (appendix 1).2,3 By using appropriate 
International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic 
codes (appendix 2), we also identified conditions that were the likely proximate etiologies of 
maternal cardiac arrest: postpartum and antepartum hemorrhage, heart failure or 
cardiomyopathy, amniotic fluid embolism, sepsis, anesthesia complications, aspiration 
pneumonitis, venous thrombo embolism, puerperal cerebrovascular disorder, trauma, 
pulmonary edema, acute myocardial infarction, magnesium toxicity, status asthmaticus, and 
anaphylaxis. Conditions that affected fewer than 10 women with cardiopulmonary arrest 
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were not considered for further analysis, in compliance with the Healthcare Cost and 
Utilization Project data use agreement and to ensure patient privacy.
Statistical Analysis
We obtained estimates of the number of U.S. delivery hospitalizations complicated by 
maternal arrest and by each of the risk factors and potential etiologies of interest by 
weighting the patient-level discharge data in the NIS files using the svyset and discwt prefix 
commands in Stata Statistical Software: Release 12.1 (StataCorp LP, College Station, TX). 
For all analyses, the criterion used for statistical significance was P value less than 0.01, to 
ensure an appropriate level of confidence given the large size of the dataset. Statistical 
testing took into account the weighted data and the stratified sampling design of the NIS. 
Data were complete except for race (n = 13,351,842 [23.5%]), survival (n = 11,061 
[0.02%]), age (n = 30,835 [0.1%]), and primary payer (n = 127,369 [0.2%]). Patients with 
missing race were recorded as “missing” and were retained in the analyses. Patients with 
missing age or primary payer were excluded from the multivariable analyses. Patients with 
missing data on survival were excluded from analyses of survival to hospital discharge.
To identify maternal sociodemographic characteristics, medical conditions, and obstetric 
conditions and procedures that are independently associated with maternal cardiopulmonary 
arrest, we constructed a multivariable logistic regression model forcing all relevant 
covariates into the model simultaneously. For this modeling, age was categorized as younger 
than 20, 20 to 34, 35 to 39, and 40 yr or older, in accordance with the categories established 
by the U.S. Centers for Disease Control and Prevention.4 Additional variables included in 
the model included race/ethnicity, primary payer, maternal medical conditions, and obstetric 
complications and procedures (as listed in appendix 1). Resulting odds ratios and 99% CIs 
for the covariates are reported. This analysis was repeated excluding from the model cases 
with cesarean delivery or stillbirth, conditions which are subject to reverse causation (i.e., 
maternal arrest may result in emergent cesarean delivery and/or fetal demise).
The frequency of conditions with the potential to cause cardiac arrest (appendix 2) was 
evaluated among the population of women diagnosed with cardiac arrest to identify the most 
common potential etiologies of cardiac arrest during the hospitalization for delivery. The 
frequency of arrest among women diagnosed with each condition was examined to identify 
the likelihood of arrest for each of these conditions. Because a small number of cardiac 
arrest cases associated with several conditions could result in unreliable estimates, a relative 
standard error (standard error/weighted estimate) for each estimate was calculated. Estimates 
may not be reliable if the corresponding relative standard error exceeds 0.30.
To evaluate temporal trends in maternal cardiac arrest and survival, we determined the 
frequency of arrest in each year of the study period, as well as the in-hospital survival for 
those patients who arrested. We tested for temporal trend in the occurrence of maternal 
arrest and in survival using univariate logistic regression, modeling year of delivery as a 
continuous independent variable. We next used multivariable logistic regression models to 
assess whether temporal trends in cardiac arrest were independent of secular trends in 
maternal sociodemographics characteristics, medical conditions, and obstetric conditions 
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and procedures (appendix 1), and whether trends in survival were independent of trends in 
the proximate etiologies of arrest.
We then determined the frequency of arrest and survival after arrest stratified by annual 
hospital delivery volume. Annual delivery volume for each hospital was calculated, by year, 
using unique hospital-identifying codes. We stratified annual delivery volume into four 
categories, 1,000 or less, 1,001 to 2,000, 2,001 to 4,000, and greater than 4,000, 
corresponding to low, low–moderate, moderate–high, and high delivery volume centers. 
Differences between the hospital categories in terms of arrest and survival were evaluated 
using Pearson chi-square test. The effect of hospital delivery volume on the risk of arrest 
was then estimated using a multivariable logistic regression model after adjustment for 
demographic characteristics and comorbidities/obstetric conditions. Likewise, the effect of 
hospital volume on the risk of survival after arrest was evaluated using a multivariable 
logistic regression model after adjusting for proximate etiologies of arrest.
Results
On the basis of weighted analysis, among 56,900,512 hospitalizations for delivery between 
1998 and 2011, there were 4,843 cases of cardiopulmonary arrest, corresponding to an event 
rate of 8.5 arrests per 100,000 hospitalizations for delivery (99% CI, 7.7 to 9.3 per 100,000). 
This frequency did not change over time (P = 0.017) (fig. 1). After adjustment for changes 
in patient demographic and clinical conditions, any trend in the risk of arrest over time did 
not reach the threshold for statistical significance (adjusted odds of arrest per year increase, 
0.97; 99% CI, 0.94 to 1.01; P = 0.04).
Women who suffer cardiac arrest are more likely to be aged 35 yr or older, more likely to be 
black (i.e., non- Hispanic black by U.S. Centers for Disease Control and Prevention race/
ethnicity coding), and more likely to receive care funded by Medicaid as opposed to private 
insurance (table 1). The maternal medical conditions most strongly associated with 
cardiopulmonary arrest include pulmonary hypertension, malignancy, cardiovascular disease 
(i.e., ischemic heart disease, congenital heart disease, cardiac valvular disease, and pre-
existing hypertension), liver disease, and systemic lupus erythematosus. The obstetric 
conditions most strongly associated with cardiac arrest include stillbirth, cesarean delivery, 
severe preeclampsia/eclampsia, and placenta previa. After excluding cesarean delivery and 
stillbirth from the multivariable model to predict cardiac arrest, the effect size estimates for 
severe preeclampsia/eclampsia and placenta previa increased, but all other estimates 
remained stable (data not shown).
The potential etiologies of arrest are listed in table 2. Hemorrhagic conditions including 
antepartum hemorrhage and postpartum hemorrhage contributed to 38.1% of all cases. Heart 
failure, amniotic fluid embolism, sepsis, anesthesia complications, aspiration pneumonitis, 
venous thromboembolism, and eclampsia each contributed to between 6 and 14% of cases. 
Amniotic fluid embolism was the diagnosis most frequently complicated by cardiac arrest, 
followed by acute myocardial infarction and venous thromboembolism (table 2). Even 
though postpartum and antepartum hemorrhage were the leading potential etiologies of 
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cardiac arrest during the hospitalization for delivery, fewer than 1 in 1,000 women who 
experienced antepartum or postpartum hemorrhage also experienced cardiac arrest.
Overall, 59.0% of women (99% CI, 54.9 to 63.1%) who suffered cardiac arrest survived to 
hospital discharge. Survival, which varied substantially by potential etiology, was lowest for 
aortic dissection or rupture and trauma and highest for aspiration pneumonitis and 
medication-related complications including anaphylaxis, local anesthetic toxicity, 
magnesium toxicity, and anesthesia-related complications (table 2). Survival improved 
during the time period studied (P = 0.001) (fig. 2). After adjustment for changes in the 
potential etiologies in arrest, the temporal trend toward improved survival persisted (odds of 
survival per year increase, 1.07; 99% CI, 1.03 to 1.12).
Of those women with cardiac arrest, 74.0% had one of the coexisting diagnoses considered 
as a potential etiology of arrest. There was no difference in survival between those with 
(58.1%) and those without (61.2%) a coexisting diagnostic code with the potential to cause 
the cardiac arrest (P = 0.06).
Frequency of cardiopulmonary arrest varied by annual hospital delivery volume (P = 
0.0036) and was more frequent in facilities with more than 1,000 deliveries per year when 
compared with smaller volume facilities (fig. 3A); these differences were no longer 
significant after adjustment for differences in maternal demographic characteristics, 
comorbidities, and obstetric conditions. Survival did not vary based on delivery volume (fig. 
3B) (P = 0.25), even after adjusting for the distribution of potential etiologies of arrest.
Discussion
By using a nationally representative sample of admission for delivery in the United States 
during a 14-yr period, we found that approximately 1 in 12,000 hospitalizations is 
complicated by maternal cardiac arrest. Although hemorrhage accounts for the largest 
fraction of maternal arrests, amniotic fluid embolism has the strongest disease-specific 
association with cardiac arrest. Survival to hospital discharge is highly dependent on the 
arrest etiology and is lowest for aortic dissection or rupture and trauma and highest for 
aspiration pneumonitis and medication-related complications including anaphylaxis, local 
anesthetic toxicity, magnesium toxicity, and anesthesia-related complications. Whereas the 
frequency of arrest has been fairly stable over the past decade, survival has improved. This 
study provides population-based data that extend the findings of case reports and series and 
can serve as the basis for programmatic changes in the preparation and management for 
maternal cardiac arrest.
Although these data verify that maternal cardiopulmonary arrest is a rare complication, they 
do not confirm the perception that the rate of arrests per year is increasing. Similarly, the 
Scottish Confidential Audit of Severe Maternal Morbidity found a stable rate of cardiac 
arrest between 2003 and 2011 in their population-based data.5–7 Notably, cardiac arrest 
seems to be more common during hospitalization for delivery in the United States than in 
Scotland, where 20 cardiac arrests were reported between 2003 and 2011,5 corresponding to 
an event rate of 3.9 per 100,000 live births (95% CI, 2.2 to 5.6).‡ The Scottish surveillance 
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system relies on active reporting by designated midwife coordinators for each delivery unit, 
whereas the current study relied on administrative codes for cardiac arrest. Although the 
frequency of cardiac arrest may be higher in the United States, it is also possible that the 
threshold for submitting hospital charges is lower than the threshold for completing a 
nonremunerated clinical report to a central governmental organization.
The American Heart Association8 draws from reports of maternal mortality4,6,7 in 
describing the differential diagnosis for the cause of maternal cardiac arrest. Results from 
the current analysis suggest that the etiologies of maternal cardiac arrest during admission 
for delivery are similar, but not identical, to the etiologies that underlie maternal mortality. 
Cardiomyopathy and cardiovascular disease combined constitute the leading cause of 
maternal death in the United States (24% of all deaths) and the United Kingdom (20.3%), 
resulting in cause-specific mortality ratios of 3.5 and 2.3 per 100,000 pregnancies, 
respectively.4,6,7,9 The prominence of cardiovascular disease in these reports likely reflects 
the requirement for maternal mortality surveillance data to capture all deaths that take place 
during, and up to 1 full year after, pregnancy. Conversely, hemorrhage is the leading 
potential etiology of maternal cardiac arrest during admission for delivery, accounting for 
38.1% of these events, followed by heart failure and acute myocardial infarction, which 
together account for 15.2% of all events. Although a comprehensive list of differential 
diagnoses should be considered when caring for an obstetric cardiac arrest victim, the most 
likely etiologies of cardiac arrest during the hospitalization for delivery seem to be 
hemorrhage, heart failure, amniotic fluid embolism, and sepsis.
Risk factors for maternal cardiopulmonary arrest seem to reflect the distribution of arrest 
etiologies. For example, placenta previa is a known cause of obstetric hemorrhage, is 
associated with placenta accreta, and is a plausible risk factor for hemorrhagic arrest. 
Similarly, it is conceivable that women of advanced maternal age would be at increased risk 
of arrest given their increased risk of preeclampsia and cardiac disease. Even after adjusting 
for maternal age, medical, and obstetric conditions, cardiopulmonary arrest is more common 
in minority women when compared with white women and among women with Medicaid 
insurance when compared those with private insurance. Although these associations parallel 
relationships demonstrated with maternal death,4 the genetic, behavioral, environmental, and 
health system factors that underlie these health disparities are unknown.10
An expanding body of evidence suggests that the population-level risks for serious 
complications of pregnancy have increased. Since 1998, the U.S. childbearing population 
has become older,11 and individual women are more likely to enter pregnancy with a 
chronic health condition, such as chronic hypertension12 or cardiac disease.13–15 Severe 
maternal morbidity during the hospitalization for delivery has increased particularly 
postpartum hemorrhage, acute renal failure, shock, acute myocardial infarction, respiratory 
distress syndrome, and maternal sepsis.16–18 Despite the increasing presence of these 
maternal comorbidities and complications, it is notable that the event rate of maternal 
cardiopulmonary arrest remained stable.
‡Vital Events Reference Tables 2011, Section 3: Births. General Register Office for Scotland. Available at: http:// www.gro-
scotland.gov.uk/statistics/theme/vital-events/general/ref-tables/2011/section-3-births.html. Accessed July 30, 2011.
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Survival to hospital discharge after arrest was approximately 60% in our study, and 
improved slightly during the 14 yr of this study. This rate exceeds those previously reported 
after in-hospital cardiac arrest in an obstetric population in Belgium (17%),19 in-hospital 
cardiac arrest in a nonobstetric population in the United States (21.2%),20 perioperative 
cardiac arrest for nonobstetric surgery in the United States (31.7%),21 and in a population of 
pregnant arrest victims described in a systematic review of published case reports (54%).22 
This high survival rate may reflect the relative health and fitness of the childbearing 
population, or the inclusion of postpartum cardiac arrest events. The trend toward improved 
survival persisted after adjusting for changes in the potential etiologies of arrest, possibly 
due to clinically important improvements in both clinical care and the appropriateness of the 
selected birthing setting based on the presence of maternal comorbid conditions.3 Recent 
evidence from the American Heart Association Get With the Guidelines initiative confirms 
that adherence to resuscitation guidelines improves outcomes among nonobstetric in-
hospital patients with cardiac arrest.23 However, cardiopulmonary arrest in the maternal 
population involves complexities and distractions that likely reduce the overall quality of 
resuscitation.24–26 Thus, it is difficult to assume that recent policy documents, which 
describe implementation strategies to improve performance and adherence to guidelines for 
teams providing maternal cardiopulmonary resuscitation, are responsible for this finding.27
Although cardiac arrest was most common in the largest delivery centers, events were 
observed even in centers with fewer than 1,000 deliveries per year. The event frequency is 
sufficiently rare that individual providers may encounter only one maternal cardiac arrest in 
a lifetime. This introduces significant challenges to the acquisition and maintenance of 
competency in resuscitation protocols and skills. Emergency manuals, checklists, simulation 
or team training, or a combination of interventions may help to ensure that individuals and 
teams are prepared to deliver effective and timely maternal cardiopulmonary 
resuscitation.28–30
This analysis is limited by the cross-sectional design and the use of administrative data. 
With cross-sectional analyses, it is not possible to determine the temporal relationship 
between events, specifically between delivery and cardiac arrest; event frequencies and 
survival rates for antepartum, intrapartum, and postpartum cardiac arrest may differ from the 
overall values reported in this analysis. The etiologies reported in table 2 reflect coexisting 
diagnoses that were identified among those women with a cardiac arrest, and that have the 
capacity to cause cardiac arrest. The relevant clinical records are not available to confirm the 
extent to which these diagnoses caused the arrest. Although cesarean delivery demonstrated 
at least a five-fold association with cardiac arrest when compared with vaginal delivery, this 
association may reflect perimortem cesarean delivery as an intervention to treat maternal 
cardiac arrest, rather than as a primary cause of arrest. Alternatively, cesarean delivery may 
be the mode of delivery chosen for women with high-risk conditions, such as preeclampsia 
and abnormal placentation, and may therefore be a marker for women with impending 
cardiac arrest.31 Certain diagnoses, such as placenta accreta, is not represented in the 
International Classification of Diseases, Ninth Revision, Clinical Modification coding 
system, and others, such as obesity, are not reliably coded in administrative records. Finally, 
survival to hospital discharge does not capture clinically important endpoints, such as 
neurologically intact survival or neonatal outcomes. Despite these limitations, administrative 
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data provide the best existing source of data for studying this rare yet vitally important 
problem. The NIS is the largest representative dataset available in the United States, and the 
inclusion of more than a decade of data yields sufficient power to analyze an event as rare as 
maternal cardiopulmonary arrest.
In conclusion, maternal cardiopulmonary arrest is a rare event for which resuscitation 
requires complex coordination between various specialties. Approximately 1 in 12,000 
hospitalizations for delivery is complicated by cardiac arrest, most frequently associated 
with hemorrhage, heart failure, amniotic fluid embolism, or sepsis. Survival depends on the 
likely etiology of arrest, but seems to be improving over time. The epidemiology of maternal 
cardiac arrest described in this report may be used to guide the further development of 
training courses and systems preparations to manage these life-threatening emergencies.
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What We Already Know about This Topic
• Cardiac arrest is rare during pregnancy and the postpartum period, but whether 
its incidence is changing and whether resuscitation is effective are largely 
unknown
What This Article Tells Us That Is New
• In a review from the Nationwide Inpatient Sample of over 50 million 
hospitalizations for delivery from 1998 to 2011, cardiac arrest occurred in 8.5 
per 100,000 hospitalizations, with no change in the rate over this time period
• Nearly 60% of women survived to discharge, with an increase in survival over 
this time period
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The frequency per 100,000 deliveries of maternal cardiac arrest by year, the Nationwide 
Inpatient Sample 1998–2011. Error bars denote the 99% CI.
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The frequency of survival to hospital discharge in delivery-associated cardiac arrest by year, 
the Nationwide Inpatient Sample 1998–2011. Error bars denote the 99% CI.
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By annual hospital delivery volume, the (A) frequency per 100,000 deliveries of maternal 
cardiac arrest and (B) frequency of survival to hospital discharge from maternal cardiac 
arrest, the Nationwide Inpatient Sample 1998–2011. Error bars denote the 99% CI.
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Table 1
The Association between Sociodemographic Characteristics, Maternal Medical Conditions, and Obstetric 
Conditions and Procedures and Maternal Cardiac Arrest, the Nationwide Inpatient Sample 1998–2011
Arrest, N (%) No Arrest, N (%) aOR* (99% CI)
Overall
  Age group, yr
    <20 327 (6.8) 6,021,192 (10.6) 0.8 (0.5–1.0)
    20–34 3,191 (65.9) 42,762,659 (75.2) Ref
    35–39 965 (19.9) 6,597,067 (11.6) 1.6 (1.3–2.0)†
    ≥40 359 (7.4) 1,483,916 (2.6) 2.0 (1.5–2.8)
  Race/ethnicity
    White 1,500 (31.0) 23,264,619 (40.9) Ref
    Black 1,191 (24.6) 5,914,624 (10.4) 2.3 (1.8–3.0)
    Hispanic 879 (18.1) 9,957,035 (17.5) 1.3 (1.0–1.7)
    Asian/Pacific Islander 200 (4.1) 2,042,190 (3.6) 1.4 (0.9–2.2)
    Other 195 (4.0) 2,366,238 (4.2) 1.2 (0.7–1.9)
    Unknown 878 (18.1) 13,350,964 (23.5) 1.1 (0.8–1.4)
  Primary payer
    Medicare 83 (1.7) 280,194 (0.5) 2.1 (0.8–5.1)
    Medicaid 2,209 (45.7) 22,495,861 (39.6) 1.3 (1.1–1.6)
    Private insurance 2,221 (45.9) 30,509,870 (53.7) Ref
    Self-pay 195 (4.0) 1,937,426 (3.4) 1.5 (0.9–2.2)
    No charge 18 (0.4) 131,388 (0.2) 1.7 (0.7–3.9)
    Other 112 (2.3) 1,413,565 (2.5) 1.2 (0.6–2.1)
  Maternal medical conditions
    Pulmonary hypertension 92 (1.9) 7,904 (0) 13.3 (6.0–29.6)
    Malignancy† 38 (0.8) 21,579 (0) 12.5 (4.7–33.0)
    Ischemic heart disease† 30 (0.6) 6,751 (0) 7.6 (2.1–27.5)
    Liver disease† 53 (1.1) 54,158 (0.1) 5.5 (2.3–13.1)
    Congenital heart disease† 48 (1.0) 42,600 (0.1) 4.2 (1.6–11.0)
    Systemic lupus erythematosus† 60 (1.2) 49,803 (0.1) 4.1 (1.8–9.8)
    Cardiac valvular disease 179 (3.7) 343,650 (0.6) 3.8 (2.2–6.3)
    Pre-existing hypertension 457 (9.4) 863,155 (1.5) 2.7 (1.9–3.7)
    Chronic renal disease 83 (1.7) 110,236 (0.2) 2.6 (1.2–5.5)
    Sickle cell disease† 38 (0.8) 68,711 (0.1) 2.6 (1.0–6.4)
    Drug abuse/dependance 153 (3.2) 651,875 (1.1) 1.8 (1.1–2.9)
    Asthma 258 (5.3) 1,281,158 (2.3) 1.7 (1.1–2.4)
    Diabetes mellitus 495 (10.2) 3,154,125 (5.5) 1.0 (0.8–1.4)
  Maternal obstetrical conditions/procedures
    Stillbirth 386 (8.0) 361,976 (0.6) 12.9 (9.4–17.7)
    Cesarean delivery 3,758 (77.6) 16,546,570 (29.1) 6.7 (5.4–8.3)
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Arrest, N (%) No Arrest, N (%) aOR* (99% CI)
    Severe preeclampsia/eclampsia 701 (14.5) 682,730 (1.2) 6.5 (5.0–8.3)
    Placenta previa 257 (5.3) 296,571 (0.5) 4.4 (2.9–6.5)
    Chorioamnionitis 159 (3.3) 1,013,164 (1.8) 1.3 (0.8–2.0)
    Multiple gestation 184 (3.8) 986,535 (1.7) 0.8 (0.5–1.3)
Bold font denotes a statistically significant result.
*
On the basis of weighted analysis, age was missing for 30,835 individuals (0.05%) and primary payer was missing for 127,369 (0.2%). Patients 
with missing values for either of these variables were excluded from the logistic regression model (n = 158,164, 0.3%).
†
Estimates with a relative standard error (i.e., standard error/weighted estimate) >0.30 may not be reliable.
aOR = adjusted odds ratio; N = number; Ref = referent category.
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Table 2
Distribution of Maternal Cardiac Arrests (n = 4,843), the Nationwide Inpatient Sample 1998–2011
Potential Proximate Etiology of
Maternal Cardiac Arrest, N (%)
Cause-specific Cardiac Arrest 
Frequency
per 1,000 Women with Each Condition
Survival to Hospital
Discharge,* N (%)
Postpartum hemorrhage 1,349 (27.9) 0.8 739 (55.1)
Antepartum hemorrhage 813 (16.8) 0.9 433 (53.2)
Heart failure 645 (13.3) 15.6 458 (71.1)
Amniotic fluid embolism 645 (13.3) 252.7 337 (52.5)
Sepsis 544 (11.2) 2.1 256 (46.9)
Anesthesia complication 379 (7.8) 29.5 310 (81.9)
Aspiration pneumonitis 346 (7.1) 20.3 287 (82.9)
Venous thrombo embolism 346 (7.1) 43.9 144 (41.5)
Eclampsia 296 (6.1) 6.2 226 (76.5)
Puerperal cerebrovascular disorder 212 (4.4) 13.6 85 (40.0)
Trauma 125 (2.6) 3.9 29 (23.3)
Pulmonary edema 118 (2.4) 11.2 83 (70.9)
Acute myocardial infarction 150 (3.1) 89.8 85 (56.3)
Magnesium toxicity 66 (1.4) 5.2 57 (85.9)
Status asthmaticus† 54 (1.1) 12.6 29 (53.7)
Anaphylaxis† 15 (0.3) 10.8 15 (100)
Aortic dissection/rupture† 14 (0.3) 31.0 0
Numbers of arrests from local anesthetic toxicity cannot be reported due to restrictions on reporting small cell sizes.
*
Survival is missing for 0.2% of those with cardiopulmonary arrest.
†
Estimates with a relative standard error (i.e., standard error/weighted estimate) >0.30 may not be reliable.
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Appendix 1
ICD-9 CM Definitions for Maternal Conditions
ICD-9 CM Definition
Malignancy 140.x–208.x
Pulmonary hypertension 416.0, 416.8, 416.9
Chronic ischemic heart disease 412.x–414.x
Congenital heart disease 745.0x–747.4x, 648.5x
Valvular heart disease 394.x–397.x, 424.x
Pre-existing hypertension 401.x–405.x, 642.0x–642.2x, 642.7x
Liver disorders in pregnancy 647.x
Systemic lupus erythematosus 710.0x
Drug abuse or dependance 304.x–305.0x, 305.2x–305.9x, 648.3x
Asthma 493.x
Chronic renal disease 581.x–583.x, 585.x, 587.x, 646.2x
Sickle cell disease 282.4x, 282.6x
Diabetes mellitus 250.x, 648.0x, 648.8x
Stillbirth 656.4x, V27.1, V27.3, V27.4, V27.6, V27.7
Severe preeclampsia/eclampsia 642.5x–642.6x
Cesarean delivery 74.0x–74.2x, 74.4, 74.99
Placenta previa 641.0x, 641.1x
Chorioamnionitis 658.4x
Multiple gestation V27.2–V27.8, 651.x
ICD-9 CM = International Classification of Diseases, Ninth Revision, Clinical Modification.
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Appendix 2
Maternal Conditions with the Potential to Cause Cardiac Arrest
ICD-9 CM Definition
Postpartum hemorrhage 665.2x, 665.3x, 666.x
Antepartum hemorrhage 641.1x–641.9x, 665.0x, 665.1x
Heart failure 415.0x, 425.x, 428.x, 429.83, 674.5x
Amniotic fluid embolism 673.1x
Sepsis 038.x, 670.x, 995.91, 995.92
Severe anesthesia complications 668.0–668.2x, 995.86
Aspiration pneumonitis 507.0, 668.0x, 997.3
Venous thromboembolism 415.1x, 673.2x
Eclampsia 642.6x
Puerperal cerebrovascular disorders 325, 346.6x, 430.x–432.x, 433.01, 433.11, 433.21, 433.31, 433.81, 433.91, 434.01, 434.11, 434.91, 
436.x, 437.1, 437.2, 437.6, 671.5x, 674.0x, 997.02
Trauma 800.x–904.x
Pulmonary edema 428.1x, 518.4x
Acute myocardial infarction 410.x, 429.5x–429.7x
Magnesium toxicity 275.2
Status asthmaticus 493.01, 493.11, 493.21, 493.91
Anaphylaxis 995.0x, 999.4x
Aortic dissection or rupture 441.0x–441.6x
Local anesthetic toxicity 968.5x
ICD-9 CM = International Classification of Diseases, Ninth Revision, Clinical Modification.
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